Updates

Idox

May 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

At the AGM, Idox said H1 sales performance had remained strong in most segments, with order intake in the first five months of the year in the core PSS division up 35% and double digit growth in the Content division. However, the business has undergone a period of reorganisation during Q1 and whilst H1 will be below last year, H2 will be better, helped by annualised savings of £7m.The core public sector software business has had several new customer wins. EIM, which supplies software for the design phase of large engineering projects, such as an oil refinery, has closed in excess of US$2m contracts. The Content business continues to perform in line with its historic double digit growth rate whilst the Healthcare side is ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Medica - Radiology recruitment jumps in Q2

Essentra

Idox (September 2023)

Idox (November 2022)

Idox (November 2021)

Idox - Looks like start of eps upgrade cycle (July 2021)

IDOX (April 2021)

Idox - Current year off to a superb start (June 2020)

IDOX (April 2020)

Idox - Disposal of loss-making arm (January 2019)

Idox (January 2018)

Idox - First acquisition under Riley (September 2017)

Idox (July 2017)

Idox - To benefit from General Election (June 2017)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X